| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 10.851 | 14.925 | 22.007 | 30.504 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 10.851 | 14.926 | 22.010 | 30.504 |
| Total Expenses - EUR | - | - | - | - | 209 | 725 | 3.300 | 8.043 | 13.282 | 28.634 |
| Gross Profit/Loss - EUR | - | - | - | - | -209 | -725 | 7.552 | 6.883 | 8.728 | 1.870 |
| Net Profit/Loss - EUR | - | - | - | - | -209 | -725 | 7.283 | 6.516 | 8.540 | 1.092 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Amolife Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 13.496 |
| Current Assets | - | - | - | - | 44 | -21 | 7.507 | 19.437 | 14.813 | 24.956 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 848 | 5.389 | 20 | 79 |
| Cash | - | - | - | - | 44 | -21 | 6.659 | 14.048 | 14.793 | 24.877 |
| Shareholders Funds | - | - | - | - | -167 | -889 | 6.415 | 6.564 | 9.712 | 5.943 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 211 | 868 | 1.092 | 12.873 | 5.101 | 32.510 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Amolife Therapy S.r.l.